Metformin attenuated the inflammation after renal ischemia/reperfusion and suppressed apoptosis of renal tubular epithelial cell in rats

Acta Cirurgica Brasileira

Volumn 30, Issue 9, 2015, Pages 617-623

  Wang, Zhi Shun ^a   Liu, Xiu Heng ^a   Wang, Min ^a   Jiang, Guan Jun ^a   Qiu, Tao ^a   Chen, Zhi Yuan ^a   Wang, Lei ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Inflammation; Ischemia; Kidney; Metformin; Rats; Reperfusion

Indexed keywords

CASPASE 3; CREATININE; CYCLOOXYGENASE 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; EPITHELIUM CELL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; MALE; NEPHRECTOMY; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; BLOOD; DRUG EFFECTS; EVALUATION STUDY; ISCHEMIC PRECONDITIONING; KIDNEY; PATHOLOGY; PROCEDURES; RANDOMIZATION; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; TIME; VASCULARIZATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; BLOOD UREA NITROGEN; BLOTTING, WESTERN; CASPASE 3; CREATININE; CYCLOOXYGENASE 2; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; KIDNEY; MALE; METFORMIN; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84944075105     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-865020150090000006     Document Type: Article

References (28)

1. Pruchnicki MC, Dasta JF. Acute renal failure in hospitalized patients:part I. Ann Pharmacother. 2002;36(7-8):1261-7. PMID: 12086561.
2. El Messaoudi S, Rongen GA, de Boer RA, Riksen NP. The cardioprotective effects of metformin. Curr Opin Lipidol. 2011;22(6):445-53. PMID: 21897229.
3. di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol. 1999;277(2 Pt 2):F195-203. PMID: 10444573.
4. Lin A, Sekhon C, Sekhon B, Smith A, Chavin K, Orak J, Singh I, Singh A. Attenuation of ischemia-reperfusion injury in a canine model of autologous renal transplantation. Transplantation. 2004;78(5):654-9. PMID: 15371664.
5. Kanellis J, Kandane RK, Etemadmoghadam D, Fraser SA, Mount PF, Levidiotis V, Kemp BE, Power DA. Activators of the energy sensing kinase AMPK inhibit random cell movement and chemotaxis in U937 cells. Immunol Cell Biol. 2006;84(1):6-12. PMID: 16405649.
6. Sag D, Carling D, Stout RD, Suttles J. Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol. 2008;181(12):8633- 41. PMID: 19050283.
7. Zhao X, Zmijewski JW, Lorne E, Liu G, Park YJ, Tsuruta Y, Abraham E. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295(3):L497-504. PMID: 18586954.
8. Arias-Negrete S, Keller K, Chadee K. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem Biophys Res Commun. 1995;208(2):582-9. PMID: 7695610.
9. Diaz A, Chepenik KP, Korn JH, Reginato AM, Jimenez SA. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp Cell Res. 1998;241(1):222-9. PMID: 9633531.
10. Chatterjee PK, Brown PA, Cuzzocrea S, Zacharowski K, Stewart KN, Mota-Filipe H, McDonald MC, Thiemermann C. Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat. Kidney Int. 2001;59(6):2073-83. PMID: 11380809.
11. Matsuyama M, Yoshimura R, Hase T, Kawahito Y, Sano H, Nakatani T. Study of cyclooxygenase-2 in renal ischemia-reperfusion injury. Transplant Proc. 2005;37(1):370-2. PMID: 15808647.
12. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation. 1983;35(3):198-204. PMID: 6340272.
13. Kellum JA, Unruh ML, Murugan R. Acute kidney injury. BMJ Clin Evid. 2011;2011. PMID: 21443811.
14. Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73. PMID: 16696865.
15. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285(2):H579-88. PMID: 12860564.
16. Hardie DG, Sakamoto K. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda). 2006;21:48-60. PMID: 16443822.
17. Krishan S, Richardson DR, Sahni S. Adenosine monophosphate-activated kinase and its key role in catabolism: structure, regulation, biologicalactivity, and pharmacological activation. Mol Pharmacol. 2015;87(3):363- 77. PMID: 25422142.
18. Corton JM, Gillespie JG, Hawley SA, and Hardie DG. 5-aminoimidazole-4- carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem. 1995;229(2):558-65. PMID: 7744080.
19. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167-74. PMID: 11602624.
20. Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, Viollet B, Thompson CB. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res. 2007;67(14):6745-52. PMID: 17638885.
21. Zhuang, Y., Miskimins, W.K. Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1. J Mol Signal. 2008;3:18. PMID: 19046439.
22. Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P, Tanti JF, Le Marchand-Brustel Y, Bost F. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene. 2008;27(25):3576-86. PMID: 18212742.
23. Bergheim I, Luyendyk JP, Steele C, Russell GK, Guo L, Roth RA, Arteel GE. Metformin prevents endotoxin-induced liver injury after partial hepatectomy. J Pharmacol Exp Ther. 2006;316(3):1053-61. PMID: 16322356.
24. Chen SQ, Liu Q, Sun H, Tang L, Deng JC. Effects of metformin on fatty liver in insulin-resistant rats. Zhonghua Gan Zang Bing Za Zhi. 2005;13(12):915-8. PMID: 16381638.
25. Hattori Y, Suzuki K, Hattori S, Kasai K. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension. 2006;47(6):1183-8. PMID: 16636195.
26. Pene F, Claessens YE, Muller O, Viguié F, Mayeux P, Dreyfus F, Lacombe C, Bouscary D. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6- kinase pathways in the proliferation and apoptosis in multiple myeloma. Oncogene. 2002;21(43):6587- 97. PMID: 12242656.
27. Seo-Mayer PW, Thulin G, Zhang L, Alves DS, Ardito T, Kashgarian M, Caplan MJ. Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia. Am J Physiol Renal Physiol. 2011;301(6):F1346-57. PMID: 21849490.
28. Bischoff A, Bucher M, Gekle M, Sauvant C. Differential effect of COX1 and COX2 inhibitors on renal outcomes following ischemic acute kidney injury. Am J Nephrol. 2014;40(1):1-11. PMID: 24943263.